Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. SWHFX: which is better?

Bottom line

XLV vs SWHFX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight.

XLV is cheaper at 0.08% vs 0.8% — a difference of $72 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +6.5% for SWHFX.

Updated Nov 19, 2026

XLV vs SWHFX side by side

XLVSWHFX
TypeETFMutual fund
Fund familySPDR (State Street)Schwab
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.8%
Annual cost per $10k$8$80
10-yr cost on $10k (prospectus)$103$990
Max front loadNone—
12b-1 fee0.02%0%
1-yr return+14.5%+15.9%
5-yr return (annualized)+8.1%+6.5%
10-yr return (annualized)+9.8%+8.1%
Best quarter+14.5%+15.3%
Worst quarter−12.7%−12.1%
Net assets (fund)$40.6B$642.3M
Number of holdings6580
Portfolio turnover2%41%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVSWHFXDifference
2025+14.5%+15.9%−1.4%
2024+2.5%+0.1%+2.4%
2023+2.0%+0.7%+1.3%
2022−2.1%−4.7%+2.6%
2021+25.9%+23.3%+2.6%
2020+13.3%+12.9%+0.4%
2019+20.7%+17.6%+3.0%
2018+6.3%+4.0%+2.3%
2017+21.7%+20.2%+1.5%
2016−2.8%−4.4%+1.5%

Source: Fund prospectus bar charts

Holdings overlap

17 of XLV's top 25 holdings also appear in SWHFX's top 25.

Shared top holdings
HoldingXLVSWHFX
Eli Lilly & Co16.51%13.92%
Johnson & Johnson10.64%6.94%
AbbVie Inc7.74%5.81%
UnitedHealth Group Inc6.57%4.74%
Merck & Co Inc5.52%4.98%
Amgen Inc3.40%2.58%
Thermo Fisher Scientific Inc3.24%2.16%
Abbott Laboratories2.75%1.60%
Gilead Sciences Inc2.73%3.24%
Vertex Pharmaceuticals Inc2.19%1.89%
Danaher Corp2.09%1.47%
Bristol-Myers Squibb Co2.05%2.44%
Stryker Corp1.89%2.11%
Medtronic PLC1.75%2.29%
Elevance Health Inc1.46%1.45%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

SWHFX top 10

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. Merck & Co Inc — 4.98%
  5. UnitedHealth Group Inc — 4.74%
  6. Gilead Sciences Inc — 3.24%
  7. Novartis AG — 2.92%
  8. Amgen Inc — 2.58%
  9. Bristol-Myers Squibb Co — 2.44%
  10. Medtronic PLC — 2.29%

FAQ

What is the difference between XLV and SWHFX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight. XLV is cheaper at 0.08% vs 0.8% — a difference of $72 a year per $10,000 invested.
Which is cheaper, XLV or SWHFX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and SWHFX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.